Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia
Siddharth Sinha, Chetna Tyagi, Sukriti Goyal, et al.
Journal of Biomolecular Structure and Dynamics (2015) Vol. 34, Iss. 10, pp. 2281-2295
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

In Silico Studies in Drug Research Against Neurodegenerative Diseases
Farahnaz Rezaei Makhouri, Jahan B. Ghasemi
Current Neuropharmacology (2017) Vol. 16, Iss. 6, pp. 664-725
Open Access | Times Cited: 63
The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
Tao Wang, Xinsong Yuan, Mianbin Wu, et al.
Expert Opinion on Drug Discovery (2017), pp. 1-16
Closed Access | Times Cited: 53
Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis: Dynamics of essential motions and free‐energy landscape analysis
Aditi Singh, Pallavi Somvanshi, Abhinav Grover
Journal of Cellular Biochemistry (2018) Vol. 120, Iss. 5, pp. 7386-7402
Closed Access | Times Cited: 43
Natural polyphenolic inhibitors against the antiapoptotic BCL-2
Sharad Verma, Aditi Singh, Anchala Kumari, et al.
Journal of Receptors and Signal Transduction (2017) Vol. 37, Iss. 4, pp. 391-400
Closed Access | Times Cited: 39
Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes
Salma Jamal, Sukriti Goyal, Asheesh Shanker, et al.
BMC Genomics (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies
Hao Zhou, Chengzhang Wang, Tao Deng, et al.
Journal of Biomolecular Structure and Dynamics (2017) Vol. 36, Iss. 8, pp. 1966-1978
Closed Access | Times Cited: 34
Drug repurposing against arabinosyl transferase (EmbC) of Mycobacterium tuberculosis: Essential dynamics and free energy minima based binding mechanics analysis
Aditi Singh, Pallavi Somvanshi, Abhinav Grover
Gene (2019) Vol. 693, pp. 114-126
Closed Access | Times Cited: 34
Role of pncA gene mutations W68R and W68G in pyrazinamide resistance
Mansi Aggarwal, Aditi Singh, Sonam Grover, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 3, pp. 2567-2578
Closed Access | Times Cited: 31
Designing potential HDAC3 inhibitors to improve memory and learning
Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha, et al.
Journal of Biomolecular Structure and Dynamics (2018) Vol. 37, Iss. 8, pp. 2133-2142
Closed Access | Times Cited: 26
Conformal prediction of HDAC inhibitors
Ulf Norinder, J. Jesús Naveja, Edgar López‐López, et al.
SAR and QSAR in environmental research (2019) Vol. 30, Iss. 4, pp. 265-277
Closed Access | Times Cited: 20
Inhibitors against New Delhi metallo-betalactamase-1 (NDM-1) and its variants endemic in Indian settings along with the laboratory functional gain mutant of NDM-1
Nabeela Farhat, Asad U. Khan
European Journal of Clinical Microbiology & Infectious Diseases (2024)
Closed Access | Times Cited: 2
Simulation Based Investigation of Deleterious nsSNPs in ATXN2 Gene and Its Structural Consequence Toward Spinocerebellar Ataxia
Siddharth Sinha, Sharad Verma, Aditi Singh, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 1, pp. 499-510
Closed Access | Times Cited: 21
Wild-type catalase peroxidase vs G279D mutant type: Molecular basis of Isoniazid drug resistance in Mycobacterium tuberculosis
Aishwarya Singh, Aditi Singh, Sonam Grover, et al.
Gene (2017) Vol. 641, pp. 226-234
Closed Access | Times Cited: 21
The QSAR Paradigm in Fragment-Based Drug Discovery: From the Virtual Generation of Target Inhibitors to Multi-Scale Modeling
Valeria V. Kleandrova, Alejandro Speck‐Planche
Mini-Reviews in Medicinal Chemistry (2020) Vol. 20, Iss. 14, pp. 1357-1374
Closed Access | Times Cited: 17
Unravelling the interaction of glipizide with human serum albumin using various spectroscopic techniques and molecular dynamics studies
Razique Anwer, Khalid I. AlQumaizi, Shafiul Haque, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 1, pp. 336-347
Closed Access | Times Cited: 15
Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs
Nabeela Farhat, Asad U. Khan
Journal of Molecular Modeling (2021) Vol. 27, Iss. 11
Open Access | Times Cited: 13
Mechanistic Insights into the Binding of Class IIa HDAC Inhibitors toward Spinocerebellar Ataxia Type-2: A 3D-QSAR and Pharmacophore Modeling Approach
Siddharth Sinha, Sukriti Goyal, Pallavi Somvanshi, et al.
Frontiers in Neuroscience (2017) Vol. 10
Open Access | Times Cited: 15
Molecular dynamics study of HDAC8-largazole analogues co-crystals for designing potential anticancer compounds
Varun Dewaker, Pratik Narain Srivastava, Saroj Verma, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 4, pp. 1197-1213
Closed Access | Times Cited: 13
Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization
Nabeela Farhat, Divya Gupta, Abid Ali, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 8
In silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship, molecular docking and pharmacokinetic parameters calculation
Neeraj Kumar, Shashank Shekher Mishra, Chandra Shekhar Sharma, et al.
Journal of Biomolecular Structure and Dynamics (2017) Vol. 36, Iss. 7, pp. 1691-1712
Closed Access | Times Cited: 12
Computational Screening and Exploration of Disease‐Associated Genes in Alzheimer's Disease
Salma Jamal, Sukriti Goyal, Asheesh Shanker, et al.
Journal of Cellular Biochemistry (2016) Vol. 118, Iss. 6, pp. 1471-1479
Closed Access | Times Cited: 8
Repurposing FDA approved drug molecules against A B C classes of β-lactamases: a computational biology and molecular dynamics simulations study
Nabeela Farhat, Asad U. Khan
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-15
Closed Access | Times Cited: 3
Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants
Sharad Verma, Sukriti Goyal, Anchala Kumari, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0190942-e0190942
Open Access | Times Cited: 8
Structure-Based Screening of Non-β-Lactam Inhibitors against Class D β-Lactamases: An Approach of Docking and Molecular Dynamics
Divya Gupta, Aditi Singh, Pallavi Somvanshi, et al.
ACS Omega (2020) Vol. 5, Iss. 16, pp. 9356-9365
Open Access | Times Cited: 7
One pot facile synthesis of flavanoidal oxadiazinanones: In vitro antibacterial activity, docking and MD simulation using DNA gyrase
Mohd Qamar, Sultanat, Shafiullah, et al.
Journal of Molecular Structure (2021) Vol. 1251, pp. 131944-131944
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top